T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Esperion Therapeutics
ESPR
$550M
| $273K | ﹤0.01% |
123,896
+16,404
| +15% | +$36.1K |
|
2527
Mercantile Bank Corp
MBWM
$777M
| $273K | ﹤0.01% |
6,133
+996
| +19% | +$44.3K |
|
2528
Orrstown Financial Services
ORRF
$682M
| $273K | ﹤0.01% |
7,456
+1,441
| +24% | +$52.8K |
|
2529
Clearfield
CLFD
$465M
| $272K | ﹤0.01% |
8,762
-31,373
| -78% | -$974K |
|
2530
Dave Inc
DAVE
$2.93B
| $272K | ﹤0.01% |
+3,120
| New | +$272K |
|
2531
LoveSac
LOVE
$254M
| $272K | ﹤0.01% |
11,462
+1,333
| +13% | +$31.6K |
|
2532
NB Bancorp
NBBK
$740M
| $272K | ﹤0.01% |
15,032
+2,297
| +18% | +$41.6K |
|
2533
Quantum Corp
QMCO
$96.2M
| $272K | ﹤0.01% |
+5,030
| New | +$272K |
|
|
PTVE
2534
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $272K | ﹤0.01% |
15,541
+2,573
| +20% | +$45K |
|
2535
Horizon Bancorp
HBNC
$840M
| $270K | ﹤0.01% |
16,723
+2,638
| +19% | +$42.6K |
|
|
PLL
2536
DELISTED
Piedmont Lithium
PLL
| $269K | ﹤0.01% |
30,691
+992
| +3% | +$8.7K |
|
2537
American Axle
AXL
$720M
| $267K | ﹤0.01% |
45,797
+8,067
| +21% | +$47K |
|
2538
National Bankshares
NKSH
$194M
| $267K | ﹤0.01% |
9,288
+447
| +5% | +$12.9K |
|
|
ORC
2539
Orchid Island Capital
ORC
$1.05B
| $267K | ﹤0.01% |
34,290
-18,733
| -35% | -$146K |
|
2540
RE/MAX Holdings
RMAX
$195M
| $266K | ﹤0.01% |
24,887
+1,154
| +5% | +$12.3K |
|
|
PSTX
2541
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $266K | ﹤0.01% |
27,677
+5,491
| +25% | +$52.8K |
|
2542
Repay Holdings
RPAY
$495M
| $264K | ﹤0.01% |
34,600
+4,635
| +15% | +$35.4K |
|
2543
Akebia Therapeutics
AKBA
$780M
| $263K | ﹤0.01% |
137,905
+11,257
| +9% | +$21.5K |
|
2544
Daktronics
DAKT
$1.04B
| $263K | ﹤0.01% |
15,599
+3,746
| +32% | +$63.2K |
|
2545
First US Bancshares
FUSB
| $263K | ﹤0.01% |
20,950
| – | – |
|
2546
MeridianLink
MLNK
$1.47B
| $263K | ﹤0.01% |
+12,702
| New | +$263K |
|
2547
TaskUs
TASK
$1.56B
| $263K | ﹤0.01% |
15,500
| – | – |
|
2548
Ribbon Communications
RBBN
$701M
| $261K | ﹤0.01% |
62,604
+4,978
| +9% | +$20.8K |
|
2549
Patria Investments
PAX
$2.29B
| $260K | ﹤0.01% |
22,319
+4,459
| +25% | +$51.9K |
|
2550
Quad
QUAD
$329M
| $260K | ﹤0.01% |
37,246
+1,629
| +5% | +$11.4K |
|